z-logo
open-access-imgOpen Access
The Potential of Pharmacogenomics to Advance Kidney Disease Treatment
Author(s) -
Kelly A. Birdwell,
Cecilia P. Chung
Publication year - 2017
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.05170517
Subject(s) - pharmacogenomics , medicine , drug , pharmacogenetics , clopidogrel , tacrolimus , cyp2c19 , pharmacology , efficacy , precision medicine , intensive care medicine , antiplatelet drug , transplantation , genotype , biology , pathology , myocardial infarction , metabolism , biochemistry , gene , cytochrome p450

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom